Monoclonal Antibodies as Therapeutic Agents
Monoclonal Antibodies as Therapeutic Agents
Fundamentals, Therapeutic Applications and Latest Advances
26 seminar style audio visual talks presented by leading world experts
Purchase Information
Target Audience
For all those wishing to be briefed on the latest developments in the study and understanding of monoclonal antibodies including researchers, scientists and advanced students of graduate courses in pathology, immunology, cancer, medicine, hematology, infectious diseases, autoimmunity and transplantation of organs and stem cells, researchers in the pharmaceutical industry and those in the venture capital and investment community.
Series Editor
Professor Herman Waldmann. Sir William Dunn School of Pathology, University of Oxford, UK.
Participating Speakers
Prof. Kari Alitalo, Prof. James Allison, Prof. Neil Barclay, Dr. Marianne Brüggemann, Prof. Dennis Burton, Prof. Lucienne Chatenoud, Dr. Mike Clark, Dr. Alasdair Coles, Prof. Alastair Compston, Prof. Marc Feldmann, Prof. Mark Greene, Prof. Geoffrey Hale, Prof. Reuben Harris, Prof. John Isaacs, Prof. Christian Larsen, Prof. David Mason, Prof. Michael Neuberger, Dr. Bronislaw Pytowski, Prof. Kanti Rai, Prof. Ben Seon, Prof. Terry Strom, Prof. Thomas Tedder, Prof. Laurence Turka, Prof. Herman Waldmann, Prof. Thomas Waldmann, Prof. Sir Gregory Winter.
Topics Covered
Improving on "natural" rodent antibodies – Antibodies in cancer therapy – Diagnostic antibodies – Cell surface glycoproteins on cells of the immune system – Antibodies as immunosuppressants – Antibodies in protection against microbial disease.
The Format
Each of the seminars is specially commissioned from a leading world expert in a user friendly format of animated slides with synchronized narration. The talks preserve each speaker’s personality and approach allowing you to experience world class seminars at your own pace, wherever you want and as often as you want.
"This series constitutes a multimedia extravaganza on the applications of mAbs as diagnostic and therapeutic agents. The format, 50 minute talks by leading experts, has some unusual features; in some cases the speakers adopt an instructive approach, and in other cases adopt a grand and fulsome presentation style, making you feel you are in the front row of a movie premiere. The cumulative effect of 26 talks is a quantum leap for the field and provides a most valuable teaching aid and educational tool."
Prof. Wayne Hancock, Professor, Pathology and Laboratory Medicine, University of Pennsylvania, USA